Citations

Mayo Clinic

Showing 10 of 108551 citations.

Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?
Toussi, Amir , Stewart‐Merrill, Suzanne B., Boorjian, Stephen A. , Psutka, Sarah P. , Thompson, R. Houston, Frank, Igor, Tollefson, Matthew K. , Gettman, Matthew T., Carlson, Rachel E. , Rangel, Laureano J. , Karnes, R. Jeffrey , Psutka, Sarah P

Journal of Urology | December 23, 2015 | Volume: 195 | Issue: 6 | Pages: 1754-1759

10.1016/j.juro.2015.12.075 | PMID 26721226 Get It

N‐Phenylbenzamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore
Roy, Sudeshna , Šileikytė, Justina , Neuenswander, Benjamin, Hedrick, Michael P., Chung, Thomas D.Y. , Schoenen, Frank J. , Forte, Michael , Bernardi, Paolo , Aubé, Jeffrey

ChemMedChem | December 23, 2015 | Volume: 11 | Issue: 3 | Pages: 283-288

10.1002/cmdc.201500545 | PMID 26693836 Get It

AbstractPersistent opening of the mitochondrial permeability transition pore (PTP), an inner membrane channel, leads to mitochondrial dysfunction and renders the PTP a therapeutic target for a host of life‐threatening diseases. Herein, we report our effort toward identifying small‐molecule inhibitors of this target through structure–activity relationship optimization studies, which led to the identification of several potent analogues around the N‐phenylbenzamide compound series identified by high‐throughput screening. In particular, compound 4 (3‐(benzyloxy)‐5‐chloro‐N‐(4‐(piperidin‐1‐ylmethyl)phenyl)benzamide) displayed noteworthy inhibitory activity in the mitochondrial swelling assay (EC50=280 nm), poor‐to‐very‐good physicochemical as well as in vitro pharmacokinetic properties, and conferred very high calcium retention capacity to mitochondria. From the data, we believe compound 4 in this series represents a promising lead for the development of PTP inhibitors of pharmacological relevance.
Pharmacologic resistance in colorectal cancer: a review
Hammond, William A. , Swaika, Abhisek, Mody, Kabir

Therapeutic Advances in Medical Oncology | December 23, 2015 | Volume: 8 | Issue: 1 | Pages: 57-84

10.1177/1758834015614530 | PMID 26753006 Get It

Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in both men and women worldwide. This is in spite of widespread, effective measures of preventive screening, and also major advances in treatment options. Despite advances in cytotoxic and targeted therapy, resistance to chemotherapy remains one of the greatest challenges in long-term management of incurable metastatic disease and eventually contributes to death as tumors accumulate means of evading treatment. We performed a comprehensive literature search on the data available through PubMed, Medline, Scopus, and the ASCO Annual Symposium abstracts through June 2015 for the purpose of this review. We discuss the current state of knowledge of clinically relevant mechanisms of resistance to cytotoxic and targeted therapies now in use for the treatment of CRC.
Ontogenic growth as the root of fundamental differences between childhood and adult cancer
Werner, Benjamin , Traulsen, Arne , Dingli, David , Dingli, David

Stem Cells | December 22, 2015 | Volume: 34 | Issue: 3 | Pages: 543-550

10.1002/stem.2251 | PMID 26689724 Get It

AbstractCancer, the unregulated proliferation of cells, can occur at any age and may arise from almost all cell types. However, the incidence and types of cancer differ with age. Some cancers are predominantly observed in children, others are mostly restricted to older ages. Treatment strategies of some cancers are very successful and cure is common in childhood, while treatment of the same cancer type is much more challenging in adults. Here, we develop a stochastic model of stem cell proliferation that considers both tissue development and homeostasis and discuss the disturbance of such a system by mutations. Due to changes in population size, mutant fitness becomes context dependent and consequently the effects of mutations on the stem cell population can vary with age. We discuss different mutant phenotypes and show the age dependency of their expected abundances. Most importantly, fitness of particular mutations can change with age and advantageous mutations can become deleterious or vice versa. This perspective can explain unique properties of childhood disorders, for example, the frequently observed phenomenon of a self-limiting leukemia in newborns with trisomy 21, but also explains other puzzling observations such as the increased risk of leukemia in patients with bone marrow failure or chemotherapy induced myelodysplasia.
Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta‐analysis
Ungprasert, Patompong , Srivali, Narat , Kittanamongkolchai, Wonngarm , Srivali, Narat

International Journal of Rheumatic Diseases | December 22, 2015 | Volume: 20 | Issue: 4 | Pages: 434-441

10.1111/1756-185x.12820 | PMID 26692475 Get It

AbstractAimsPatients with rheumatoid arthritis (RA) might be at an increased risk of developing atrial fibrillation (AF) as a result of deleterious effects of inflammatory cytokines on cardiomyocytes. This study aimed to comprehensively review all available evidence to further characterize this possible association.MethodsWe conducted a systematic review and meta‐analysis of cohort studies that reported relative risk, hazard ratio, incidence ratio or standardized incidence ratio with 95% confidence intervals comparing the risk of incidence of AF in patients with RA versus non‐RA participants. Pooled risk ratio and 95% confidence interval were calculated using random‐effect, generic inverse‐variance methods of DerSimonian and Laird.ResultsThree retrospective cohort studies with 39 912 cases of RA and 4 269 161 non‐RA controls were included in the data analysis. The pooled risk ratio of subsequent development of AF in patients with RA versus controls was 1.29 (95% CI, 1.05–1.59). The statistical heterogeneity was moderate with an I2 of 71%.ConclusionOur meta‐analysis demonstrated a statistically significant increased risk of subsequent development of AF among patients with RA.
BMI changes in adolescents treated with bupropion SR for smoking cessation
Floden, Lysbeth , Taren, Douglas , Muramoto, Myra , Leischow, Scott J.

Obesity | December 22, 2015 | Volume: 24 | Issue: 1 | Pages: 26-29

10.1002/oby.21360 | PMID 26692579 Get It

ObjectiveAdolescent overweight and obesity and smoking continue to be very important health challenges because of their lasting effects on overall health. Weight gain after smoking cessation is a barrier to quitting as well as a negative consequence to health. This study reports changes in the body mass index (BMI) z‐scores of adolescent smokers participating in a dose‐ranging clinical trial of bupropion SR (150 mg/day and 300 mg/day) for smoking cessation.MethodsA total of N = 296 adolescent smokers (placebo n = 100, 150 mg/day n = 101, 300 mg/day n = 95) with a BMI z‐score of 0.5 (sd: 1.4), 0.5 (sd: 1.3), and 0.5 (sd: 1.2) in the placebo, 150 mg/day, and 300 mg/day groups, respectively, were followed for 6 months.ResultsAdolescents in the 300 mg/day group had a significant reduction in BMI z‐score 6 weeks after quitting (β = −0.16, CI = (−0.29, −0.04), P‐value = 0.01). This result was not sustained at the 6‐month follow‐up.ConclusionsA reduction in BMI z‐score during smoking cessation with bupropion has important implications for the future of adolescent smoking cessation. These results are particularly relevant for adolescents who have either overweight or obesity or who have reservations about quitting for fear of gaining weight or BMI.
Southwestern Aging and Geriatrics Education Scholars: Effectiveness of a Geriatrics Education Innovative Small Grants Program
Kirk, Lynne M. , Shah, Amit , Rubin, Craig D. , Shah, Amit A, Shah, Amit A

Journal of the American Geriatrics Society | December 22, 2015 | Volume: 63 | Issue: 12 | Pages: 2624-2625

10.1111/jgs.13844 | PMID 26691701 Get It

Bioinnovation Enterprise: An engine driving breakthrough therapies
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Clinical Pharmacology & Therapeutics | December 22, 2015 | Volume: 99 | Issue: 1 | Pages: 8-13

10.1002/cpt.272 | PMID 26785918 Get It

Biological advances have radically expanded our insights into the underpinnings of health and disease. New knowledge has formed the substrate for translation—expedited in turn by the biotechnology and pharmaceutical industry into novel therapeutic solutions impacting the management of patients and populations. Indeed, this Bioinnovation Enterprise has become the dominant growth sector in drug development and the engine driving the translation of breakthrough therapies worldwide. This annual Therapeutic Innovations issue highlights recent exceptional advances by the Bioinnovation Enterprise in translating molecular insights in pathobiology into transformative therapies.
Performance of magnetic resonance elastography in primary sclerosing cholangitis
Eaton, John E. , Dzyubak, Bogdan , Venkatesh, Sudhakar K. , Smyrk, Thomas C. , Gossard, Andrea A., Lazaridis, Konstantinos N. , Gores, Gregory J. , Ehman, Richard L. , LaRusso, Nicholas F. , Dzyubak, Bogdan , Venkatesh, Sudhakar K

Journal of Gastroenterology and Hepatology | December 22, 2015 | Volume: 31 | Issue: 6 | Pages: 1184-1190

10.1111/jgh.13263 | PMID 26691631 Get It

AbstractBackground and Aim:Liver stiffness (LS) measured by magnetic resonance elastography (MRE) is emerging as an important biomarker in chronic liver diseases. We examined the diagnostic performance of MRE, factors associated with an increased LS and the prognostic value of LS as measured by MRE among patients with primary sclerosing cholangitis (PSC).Methods:We performed a retrospective review of 266 patients with PSC to examine whether LS was associated with the primary endpoint of hepatic decompensation (ascites, variceal hemorrhage and hepatic encephalopathy). The ability of MRE to differentiate stages of fibrosis was examined in a subset of patients who underwent a liver biopsy (n = 20).Results:An LS of 4.93 kPa was the optimal point to detected F4 fibrosis (sensitivity, 1.00; 95% confidence interval (CI), 0.40–1.00; specificity, 0.94; 95%CI, 0.68–1.00). While a serum alkaline phosphatase <1.5 times the upper limit of normal excluded the presence of advanced LS, it was not associated with the primary endpoint (hazard ratio, 0.26; 95%CI, 0.01–1.33). However, LS was associated with the development of decompensated liver disease (hazard ratio, 1.55; 95%CI, 1.41–1.70). The optimal LS thresholds that stratified patients at a low, medium and high risk for hepatic decompensation were <4.5, 4.5–6.0 and >6.0 kPa (respectively).Conclusion:Magnetic resonance elastography is able to detect cirrhosis with high specificity and an alkaline phosphatase <1.5 times the upper limit of normal makes the presence of advanced LS unlikely. Moreover, LS obtained by MRE is predictive of hepatic decompensation in PSC.